Focus:
Cardiovascular
-
27 January 2020 pressreleases
Greiner Bio-One Supports the Swiss Red Cross in Lebanon
Greiner Bio-One is supporting a Swiss Red Cross (SRK) project to modernise the blood donor service and the provision of safe blood supplies for Syrian refugees and the wider public...
-
20 January 2020 News
Holding breath could improve radiotherapy for cardiac arrhythmias
Patients holding their breath for five minutes or more could be used to support an emerging new radiotherapy technique for cardiac ablation, according to researchers at the University of Birmingham.
-
10 January 2020 News
Cardiologs raises $15m in Series A funding
Artificial intelligence (AI) cardiology diagnostics firm Cardiologs has secured $15m in Series A funding, bringing the total capital raised since its inception to $25m.
-
10 January 2020 News
Reflow obtains breakthrough designation for spur stent system
Reflow Medical has received breakthrough device designation for its Temporary Spur Stent System from the US Food and Drug Administration (FDA).
-
10 January 2020 projects
HeartMate III Heart Pump
HeartMate III™ is an advanced left ventricular assist device (LVAD) approved for use in advanced heart failure patients who require short or long-term mechanical cardiovascular support such as bridge to...
-
8 January 2020 News
Abbott receives FDA approval for heart pump implant procedure
Abbott has secured approval from the US Food and Drug Administration (FDA) for its less-invasive heart pump implant procedure to help patients avoid open heart surgery.
-
24 December 2019 Comment
LifeMatrix set to disrupt cardiovascular implant market with scalable tissue engineering technology
LifeMatix is a scalable tissue engineering technology that creates novel biomimetic cardiovascular implants with capacity for self-renewal, remodelling and growth.
-
19 December 2019 News
FDA grants breakthrough status to Eko’s ECG-based algorithm
Digital health firm Eko Devices has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its ECG-based low ejection fraction screening algorithm.
-
16 December 2019 News
Reprieve Cardiovascular reports results of fluid management trial
US-based Reprieve Cardiovascular has announced that the first-in-human clinical trial of its fully automated fluid management system, Personalized Volume Management System (PVM), has indicated effective and long-lasting decongestion in patients...
-
5 December 2019 News
Anaconda Biomed raises €20m to advance thrombectomy systems
Barcelona-based medical device company Anaconda Biomed has raised €20m in a funding round, with plans to use the proceeds for clinical studies, regulatory submissions, product development and manufacturing scale-up.